1
  • Category
  • Region
U.S. (TOLL FREE)
+1 (315) 215-3225
1
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Hemostatic Materials Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-36Z14374
Home | Market Reports | Health| Medical Devices & Equipment
Global Hemostatic Materials Market Research Report 2023
BUY CHAPTERS

Global Hemostatic Materials Market Research Report 2025

Code: QYRE-Auto-36Z14374
Report
March 2025
Pages:103
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Hemostatic Materials Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Hemostatic Materials Market

Hemostatic Materials Market

The global market for Hemostatic Materials was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Hemostatic Materials, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemostatic Materials.
The Hemostatic Materials market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hemostatic Materials market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hemostatic Materials manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Hemostatic Materials Market Report

Report Metric Details
Report Name Hemostatic Materials Market
Accounted market size in year US$ 603 billion
CAGR 5%
Base Year year
Segment by Type
  • Mechanical Hemostatic Agent
  • Adhesive Hemostatic Agent
Segment by Application
  • Hospital
  • Clinics
  • Beauty Salon
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Johnson & Johnson, BD, Baxter, B.Braun, Cura Medical, GELITA MEDICAL, Curasan AG, Meril Life Sciences, Zhonghui Shengxi, Beijing Datsing Bio-tech, Guizhou Jin Jiu Biotech, Beijing Taikesiman, Foryou Medical, Saikesaisi Holdings Group, Biotemed, YEK, HanBang, Trauer
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Hemostatic Materials manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Hemostatic Materials in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Hemostatic Materials Market report?

Ans: The main players in the Hemostatic Materials Market are Johnson & Johnson, BD, Baxter, B.Braun, Cura Medical, GELITA MEDICAL, Curasan AG, Meril Life Sciences, Zhonghui Shengxi, Beijing Datsing Bio-tech, Guizhou Jin Jiu Biotech, Beijing Taikesiman, Foryou Medical, Saikesaisi Holdings Group, Biotemed, YEK, HanBang, Trauer

What are the Application segmentation covered in the Hemostatic Materials Market report?

Ans: The Applications covered in the Hemostatic Materials Market report are Hospital, Clinics, Beauty Salon

What are the Type segmentation covered in the Hemostatic Materials Market report?

Ans: The Types covered in the Hemostatic Materials Market report are Mechanical Hemostatic Agent, Adhesive Hemostatic Agent

1 Hemostatic Materials Market Overview
1.1 Product Definition
1.2 Hemostatic Materials by Type
1.2.1 Global Hemostatic Materials Market Value Comparison by Type (2024 VS 2031)
1.2.2 Mechanical Hemostatic Agent
1.2.3 Adhesive Hemostatic Agent
1.3 Hemostatic Materials by Application
1.3.1 Global Hemostatic Materials Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Beauty Salon
1.4 Global Hemostatic Materials Market Size Estimates and Forecasts
1.4.1 Global Hemostatic Materials Revenue 2020-2031
1.4.2 Global Hemostatic Materials Sales 2020-2031
1.4.3 Global Hemostatic Materials Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Hemostatic Materials Market Competition by Manufacturers
2.1 Global Hemostatic Materials Sales Market Share by Manufacturers (2020-2025)
2.2 Global Hemostatic Materials Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Hemostatic Materials Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Hemostatic Materials, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hemostatic Materials, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hemostatic Materials, Product Type & Application
2.7 Global Key Manufacturers of Hemostatic Materials, Date of Enter into This Industry
2.8 Global Hemostatic Materials Market Competitive Situation and Trends
2.8.1 Global Hemostatic Materials Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Hemostatic Materials Players Market Share by Revenue
2.8.3 Global Hemostatic Materials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Hemostatic Materials Market Scenario by Region
3.1 Global Hemostatic Materials Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Hemostatic Materials Sales by Region: 2020-2031
3.2.1 Global Hemostatic Materials Sales by Region: 2020-2025
3.2.2 Global Hemostatic Materials Sales by Region: 2026-2031
3.3 Global Hemostatic Materials Revenue by Region: 2020-2031
3.3.1 Global Hemostatic Materials Revenue by Region: 2020-2025
3.3.2 Global Hemostatic Materials Revenue by Region: 2026-2031
3.4 North America Hemostatic Materials Market Facts & Figures by Country
3.4.1 North America Hemostatic Materials Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Hemostatic Materials Sales by Country (2020-2031)
3.4.3 North America Hemostatic Materials Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Hemostatic Materials Market Facts & Figures by Country
3.5.1 Europe Hemostatic Materials Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Hemostatic Materials Sales by Country (2020-2031)
3.5.3 Europe Hemostatic Materials Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hemostatic Materials Market Facts & Figures by Region
3.6.1 Asia Pacific Hemostatic Materials Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Hemostatic Materials Sales by Region (2020-2031)
3.6.3 Asia Pacific Hemostatic Materials Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Hemostatic Materials Market Facts & Figures by Country
3.7.1 Latin America Hemostatic Materials Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Hemostatic Materials Sales by Country (2020-2031)
3.7.3 Latin America Hemostatic Materials Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hemostatic Materials Market Facts & Figures by Country
3.8.1 Middle East and Africa Hemostatic Materials Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Hemostatic Materials Sales by Country (2020-2031)
3.8.3 Middle East and Africa Hemostatic Materials Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hemostatic Materials Sales by Type (2020-2031)
4.1.1 Global Hemostatic Materials Sales by Type (2020-2025)
4.1.2 Global Hemostatic Materials Sales by Type (2026-2031)
4.1.3 Global Hemostatic Materials Sales Market Share by Type (2020-2031)
4.2 Global Hemostatic Materials Revenue by Type (2020-2031)
4.2.1 Global Hemostatic Materials Revenue by Type (2020-2025)
4.2.2 Global Hemostatic Materials Revenue by Type (2026-2031)
4.2.3 Global Hemostatic Materials Revenue Market Share by Type (2020-2031)
4.3 Global Hemostatic Materials Price by Type (2020-2031)
5 Segment by Application
5.1 Global Hemostatic Materials Sales by Application (2020-2031)
5.1.1 Global Hemostatic Materials Sales by Application (2020-2025)
5.1.2 Global Hemostatic Materials Sales by Application (2026-2031)
5.1.3 Global Hemostatic Materials Sales Market Share by Application (2020-2031)
5.2 Global Hemostatic Materials Revenue by Application (2020-2031)
5.2.1 Global Hemostatic Materials Revenue by Application (2020-2025)
5.2.2 Global Hemostatic Materials Revenue by Application (2026-2031)
5.2.3 Global Hemostatic Materials Revenue Market Share by Application (2020-2031)
5.3 Global Hemostatic Materials Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Company Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson Hemostatic Materials Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Johnson & Johnson Hemostatic Materials Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 BD
6.2.1 BD Company Information
6.2.2 BD Description and Business Overview
6.2.3 BD Hemostatic Materials Sales, Revenue and Gross Margin (2020-2025)
6.2.4 BD Hemostatic Materials Product Portfolio
6.2.5 BD Recent Developments/Updates
6.3 Baxter
6.3.1 Baxter Company Information
6.3.2 Baxter Description and Business Overview
6.3.3 Baxter Hemostatic Materials Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Baxter Hemostatic Materials Product Portfolio
6.3.5 Baxter Recent Developments/Updates
6.4 B.Braun
6.4.1 B.Braun Company Information
6.4.2 B.Braun Description and Business Overview
6.4.3 B.Braun Hemostatic Materials Sales, Revenue and Gross Margin (2020-2025)
6.4.4 B.Braun Hemostatic Materials Product Portfolio
6.4.5 B.Braun Recent Developments/Updates
6.5 Cura Medical
6.5.1 Cura Medical Company Information
6.5.2 Cura Medical Description and Business Overview
6.5.3 Cura Medical Hemostatic Materials Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Cura Medical Hemostatic Materials Product Portfolio
6.5.5 Cura Medical Recent Developments/Updates
6.6 GELITA MEDICAL
6.6.1 GELITA MEDICAL Company Information
6.6.2 GELITA MEDICAL Description and Business Overview
6.6.3 GELITA MEDICAL Hemostatic Materials Sales, Revenue and Gross Margin (2020-2025)
6.6.4 GELITA MEDICAL Hemostatic Materials Product Portfolio
6.6.5 GELITA MEDICAL Recent Developments/Updates
6.7 Curasan AG
6.7.1 Curasan AG Company Information
6.7.2 Curasan AG Description and Business Overview
6.7.3 Curasan AG Hemostatic Materials Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Curasan AG Hemostatic Materials Product Portfolio
6.7.5 Curasan AG Recent Developments/Updates
6.8 Meril Life Sciences
6.8.1 Meril Life Sciences Company Information
6.8.2 Meril Life Sciences Description and Business Overview
6.8.3 Meril Life Sciences Hemostatic Materials Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Meril Life Sciences Hemostatic Materials Product Portfolio
6.8.5 Meril Life Sciences Recent Developments/Updates
6.9 Zhonghui Shengxi
6.9.1 Zhonghui Shengxi Company Information
6.9.2 Zhonghui Shengxi Description and Business Overview
6.9.3 Zhonghui Shengxi Hemostatic Materials Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Zhonghui Shengxi Hemostatic Materials Product Portfolio
6.9.5 Zhonghui Shengxi Recent Developments/Updates
6.10 Beijing Datsing Bio-tech
6.10.1 Beijing Datsing Bio-tech Company Information
6.10.2 Beijing Datsing Bio-tech Description and Business Overview
6.10.3 Beijing Datsing Bio-tech Hemostatic Materials Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Beijing Datsing Bio-tech Hemostatic Materials Product Portfolio
6.10.5 Beijing Datsing Bio-tech Recent Developments/Updates
6.11 Guizhou Jin Jiu Biotech
6.11.1 Guizhou Jin Jiu Biotech Company Information
6.11.2 Guizhou Jin Jiu Biotech Description and Business Overview
6.11.3 Guizhou Jin Jiu Biotech Hemostatic Materials Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Guizhou Jin Jiu Biotech Hemostatic Materials Product Portfolio
6.11.5 Guizhou Jin Jiu Biotech Recent Developments/Updates
6.12 Beijing Taikesiman
6.12.1 Beijing Taikesiman Company Information
6.12.2 Beijing Taikesiman Description and Business Overview
6.12.3 Beijing Taikesiman Hemostatic Materials Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Beijing Taikesiman Hemostatic Materials Product Portfolio
6.12.5 Beijing Taikesiman Recent Developments/Updates
6.13 Foryou Medical
6.13.1 Foryou Medical Company Information
6.13.2 Foryou Medical Description and Business Overview
6.13.3 Foryou Medical Hemostatic Materials Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Foryou Medical Hemostatic Materials Product Portfolio
6.13.5 Foryou Medical Recent Developments/Updates
6.14 Saikesaisi Holdings Group
6.14.1 Saikesaisi Holdings Group Company Information
6.14.2 Saikesaisi Holdings Group Description and Business Overview
6.14.3 Saikesaisi Holdings Group Hemostatic Materials Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Saikesaisi Holdings Group Hemostatic Materials Product Portfolio
6.14.5 Saikesaisi Holdings Group Recent Developments/Updates
6.15 Biotemed
6.15.1 Biotemed Company Information
6.15.2 Biotemed Description and Business Overview
6.15.3 Biotemed Hemostatic Materials Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Biotemed Hemostatic Materials Product Portfolio
6.15.5 Biotemed Recent Developments/Updates
6.16 YEK
6.16.1 YEK Company Information
6.16.2 YEK Description and Business Overview
6.16.3 YEK Hemostatic Materials Sales, Revenue and Gross Margin (2020-2025)
6.16.4 YEK Hemostatic Materials Product Portfolio
6.16.5 YEK Recent Developments/Updates
6.17 HanBang
6.17.1 HanBang Company Information
6.17.2 HanBang Description and Business Overview
6.17.3 HanBang Hemostatic Materials Sales, Revenue and Gross Margin (2020-2025)
6.17.4 HanBang Hemostatic Materials Product Portfolio
6.17.5 HanBang Recent Developments/Updates
6.18 Trauer
6.18.1 Trauer Company Information
6.18.2 Trauer Description and Business Overview
6.18.3 Trauer Hemostatic Materials Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Trauer Hemostatic Materials Product Portfolio
6.18.5 Trauer Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hemostatic Materials Industry Chain Analysis
7.2 Hemostatic Materials Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hemostatic Materials Production Mode & Process Analysis
7.4 Hemostatic Materials Sales and Marketing
7.4.1 Hemostatic Materials Sales Channels
7.4.2 Hemostatic Materials Distributors
7.5 Hemostatic Materials Customer Analysis
8 Hemostatic Materials Market Dynamics
8.1 Hemostatic Materials Industry Trends
8.2 Hemostatic Materials Market Drivers
8.3 Hemostatic Materials Market Challenges
8.4 Hemostatic Materials Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Hemostatic Materials Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Hemostatic Materials Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Hemostatic Materials Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Hemostatic Materials Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Hemostatic Materials Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Hemostatic Materials Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Hemostatic Materials Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Hemostatic Materials Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Hemostatic Materials, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Hemostatic Materials, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Hemostatic Materials, Product Type & Application
 Table 12. Global Key Manufacturers of Hemostatic Materials, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Hemostatic Materials by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemostatic Materials as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Hemostatic Materials Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Hemostatic Materials Sales by Region (2020-2025) & (K Units)
 Table 18. Global Hemostatic Materials Sales Market Share by Region (2020-2025)
 Table 19. Global Hemostatic Materials Sales by Region (2026-2031) & (K Units)
 Table 20. Global Hemostatic Materials Sales Market Share by Region (2026-2031)
 Table 21. Global Hemostatic Materials Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Hemostatic Materials Revenue Market Share by Region (2020-2025)
 Table 23. Global Hemostatic Materials Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Hemostatic Materials Revenue Market Share by Region (2026-2031)
 Table 25. North America Hemostatic Materials Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Hemostatic Materials Sales by Country (2020-2025) & (K Units)
 Table 27. North America Hemostatic Materials Sales by Country (2026-2031) & (K Units)
 Table 28. North America Hemostatic Materials Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Hemostatic Materials Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Hemostatic Materials Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Hemostatic Materials Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Hemostatic Materials Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Hemostatic Materials Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Hemostatic Materials Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Hemostatic Materials Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Hemostatic Materials Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Hemostatic Materials Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Hemostatic Materials Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Hemostatic Materials Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Hemostatic Materials Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Hemostatic Materials Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Hemostatic Materials Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Hemostatic Materials Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Hemostatic Materials Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Hemostatic Materials Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Hemostatic Materials Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Hemostatic Materials Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Hemostatic Materials Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Hemostatic Materials Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Hemostatic Materials Sales (K Units) by Type (2020-2025)
 Table 51. Global Hemostatic Materials Sales (K Units) by Type (2026-2031)
 Table 52. Global Hemostatic Materials Sales Market Share by Type (2020-2025)
 Table 53. Global Hemostatic Materials Sales Market Share by Type (2026-2031)
 Table 54. Global Hemostatic Materials Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Hemostatic Materials Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Hemostatic Materials Revenue Market Share by Type (2020-2025)
 Table 57. Global Hemostatic Materials Revenue Market Share by Type (2026-2031)
 Table 58. Global Hemostatic Materials Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Hemostatic Materials Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Hemostatic Materials Sales (K Units) by Application (2020-2025)
 Table 61. Global Hemostatic Materials Sales (K Units) by Application (2026-2031)
 Table 62. Global Hemostatic Materials Sales Market Share by Application (2020-2025)
 Table 63. Global Hemostatic Materials Sales Market Share by Application (2026-2031)
 Table 64. Global Hemostatic Materials Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Hemostatic Materials Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Hemostatic Materials Revenue Market Share by Application (2020-2025)
 Table 67. Global Hemostatic Materials Revenue Market Share by Application (2026-2031)
 Table 68. Global Hemostatic Materials Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Hemostatic Materials Price (US$/Unit) by Application (2026-2031)
 Table 70. Johnson & Johnson Company Information
 Table 71. Johnson & Johnson Description and Business Overview
 Table 72. Johnson & Johnson Hemostatic Materials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Johnson & Johnson Hemostatic Materials Product
 Table 74. Johnson & Johnson Recent Developments/Updates
 Table 75. BD Company Information
 Table 76. BD Description and Business Overview
 Table 77. BD Hemostatic Materials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. BD Hemostatic Materials Product
 Table 79. BD Recent Developments/Updates
 Table 80. Baxter Company Information
 Table 81. Baxter Description and Business Overview
 Table 82. Baxter Hemostatic Materials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Baxter Hemostatic Materials Product
 Table 84. Baxter Recent Developments/Updates
 Table 85. B.Braun Company Information
 Table 86. B.Braun Description and Business Overview
 Table 87. B.Braun Hemostatic Materials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. B.Braun Hemostatic Materials Product
 Table 89. B.Braun Recent Developments/Updates
 Table 90. Cura Medical Company Information
 Table 91. Cura Medical Description and Business Overview
 Table 92. Cura Medical Hemostatic Materials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Cura Medical Hemostatic Materials Product
 Table 94. Cura Medical Recent Developments/Updates
 Table 95. GELITA MEDICAL Company Information
 Table 96. GELITA MEDICAL Description and Business Overview
 Table 97. GELITA MEDICAL Hemostatic Materials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. GELITA MEDICAL Hemostatic Materials Product
 Table 99. GELITA MEDICAL Recent Developments/Updates
 Table 100. Curasan AG Company Information
 Table 101. Curasan AG Description and Business Overview
 Table 102. Curasan AG Hemostatic Materials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Curasan AG Hemostatic Materials Product
 Table 104. Curasan AG Recent Developments/Updates
 Table 105. Meril Life Sciences Company Information
 Table 106. Meril Life Sciences Description and Business Overview
 Table 107. Meril Life Sciences Hemostatic Materials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Meril Life Sciences Hemostatic Materials Product
 Table 109. Meril Life Sciences Recent Developments/Updates
 Table 110. Zhonghui Shengxi Company Information
 Table 111. Zhonghui Shengxi Description and Business Overview
 Table 112. Zhonghui Shengxi Hemostatic Materials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Zhonghui Shengxi Hemostatic Materials Product
 Table 114. Zhonghui Shengxi Recent Developments/Updates
 Table 115. Beijing Datsing Bio-tech Company Information
 Table 116. Beijing Datsing Bio-tech Description and Business Overview
 Table 117. Beijing Datsing Bio-tech Hemostatic Materials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Beijing Datsing Bio-tech Hemostatic Materials Product
 Table 119. Beijing Datsing Bio-tech Recent Developments/Updates
 Table 120. Guizhou Jin Jiu Biotech Company Information
 Table 121. Guizhou Jin Jiu Biotech Description and Business Overview
 Table 122. Guizhou Jin Jiu Biotech Hemostatic Materials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Guizhou Jin Jiu Biotech Hemostatic Materials Product
 Table 124. Guizhou Jin Jiu Biotech Recent Developments/Updates
 Table 125. Beijing Taikesiman Company Information
 Table 126. Beijing Taikesiman Description and Business Overview
 Table 127. Beijing Taikesiman Hemostatic Materials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Beijing Taikesiman Hemostatic Materials Product
 Table 129. Beijing Taikesiman Recent Developments/Updates
 Table 130. Foryou Medical Company Information
 Table 131. Foryou Medical Description and Business Overview
 Table 132. Foryou Medical Hemostatic Materials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Foryou Medical Hemostatic Materials Product
 Table 134. Foryou Medical Recent Developments/Updates
 Table 135. Saikesaisi Holdings Group Company Information
 Table 136. Saikesaisi Holdings Group Description and Business Overview
 Table 137. Saikesaisi Holdings Group Hemostatic Materials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Saikesaisi Holdings Group Hemostatic Materials Product
 Table 139. Saikesaisi Holdings Group Recent Developments/Updates
 Table 140. Biotemed Company Information
 Table 141. Biotemed Description and Business Overview
 Table 142. Biotemed Hemostatic Materials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Biotemed Hemostatic Materials Product
 Table 144. Biotemed Recent Developments/Updates
 Table 145. YEK Company Information
 Table 146. YEK Description and Business Overview
 Table 147. YEK Hemostatic Materials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. YEK Hemostatic Materials Product
 Table 149. YEK Recent Developments/Updates
 Table 150. HanBang Company Information
 Table 151. HanBang Description and Business Overview
 Table 152. HanBang Hemostatic Materials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. HanBang Hemostatic Materials Product
 Table 154. HanBang Recent Developments/Updates
 Table 155. Trauer Company Information
 Table 156. Trauer Description and Business Overview
 Table 157. Trauer Hemostatic Materials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. Trauer Hemostatic Materials Product
 Table 159. Trauer Recent Developments/Updates
 Table 160. Key Raw Materials Lists
 Table 161. Raw Materials Key Suppliers Lists
 Table 162. Hemostatic Materials Distributors List
 Table 163. Hemostatic Materials Customers List
 Table 164. Hemostatic Materials Market Trends
 Table 165. Hemostatic Materials Market Drivers
 Table 166. Hemostatic Materials Market Challenges
 Table 167. Hemostatic Materials Market Restraints
 Table 168. Research Programs/Design for This Report
 Table 169. Key Data Information from Secondary Sources
 Table 170. Key Data Information from Primary Sources
 Table 171. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Hemostatic Materials
 Figure 2. Global Hemostatic Materials Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Hemostatic Materials Market Share by Type: 2024 & 2031
 Figure 4. Mechanical Hemostatic Agent Product Picture
 Figure 5. Adhesive Hemostatic Agent Product Picture
 Figure 6. Global Hemostatic Materials Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Hemostatic Materials Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinics
 Figure 10. Beauty Salon
 Figure 11. Global Hemostatic Materials Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Hemostatic Materials Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Hemostatic Materials Sales (2020-2031) & (K Units)
 Figure 14. Global Hemostatic Materials Average Price (US$/Unit) & (2020-2031)
 Figure 15. Hemostatic Materials Report Years Considered
 Figure 16. Hemostatic Materials Sales Share by Manufacturers in 2024
 Figure 17. Global Hemostatic Materials Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Hemostatic Materials Players: Market Share by Revenue in Hemostatic Materials in 2024
 Figure 19. Hemostatic Materials Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Hemostatic Materials Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Hemostatic Materials Sales Market Share by Country (2020-2031)
 Figure 22. North America Hemostatic Materials Revenue Market Share by Country (2020-2031)
 Figure 23. United States Hemostatic Materials Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Hemostatic Materials Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Hemostatic Materials Sales Market Share by Country (2020-2031)
 Figure 26. Europe Hemostatic Materials Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Hemostatic Materials Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Hemostatic Materials Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Hemostatic Materials Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Hemostatic Materials Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Hemostatic Materials Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Hemostatic Materials Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Hemostatic Materials Revenue Market Share by Region (2020-2031)
 Figure 34. China Hemostatic Materials Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Hemostatic Materials Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Hemostatic Materials Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Hemostatic Materials Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Hemostatic Materials Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Hemostatic Materials Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Hemostatic Materials Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Hemostatic Materials Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Hemostatic Materials Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Hemostatic Materials Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Hemostatic Materials Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Hemostatic Materials Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Hemostatic Materials Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Hemostatic Materials Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Hemostatic Materials Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Hemostatic Materials Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Hemostatic Materials Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Hemostatic Materials Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Hemostatic Materials Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Hemostatic Materials by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Hemostatic Materials by Type (2020-2031)
 Figure 55. Global Hemostatic Materials Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Hemostatic Materials by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Hemostatic Materials by Application (2020-2031)
 Figure 58. Global Hemostatic Materials Price (US$/Unit) by Application (2020-2031)
 Figure 59. Hemostatic Materials Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Apheresis Machines Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages
Type: Report
Code: QYRE-Auto-6233
Fri Mar 21 00:00:00 UTC 2025

Add to Cart

Global Surgical Stapling Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages
Type: Report
Code: QYRE-Auto-3354
Fri Mar 21 00:00:00 UTC 2025

Add to Cart

Global Blood and Fluid Warmer Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages
Type: Report
Code: QYRE-Auto-9L7040
Fri Mar 21 00:00:00 UTC 2025

Add to Cart

Add to Cart